#doctisproject 검색 결과
Avui acollim l'Assamblea General del projecte @DoctisEU en la qual es presenten els resultats obtinguts al llarg dels 5 anys de funcionament del #DocTISProject. La Dra. Begoña Benito, directora del #VHIR, ha destacat la importància de les fites aconseguides. #IMIDs
📢 As part of the #DocTISProject series, we feature Adrià Aterido, computational biologist at @VHIR_. 🧬 His work uses #MultiOmics and #SystemsBiology to uncover disease mechanisms and support therapies for #IMIDs. 👉 doctis.eu/adria-aterido-… #DataDrivenMedicine #IMID
🔬 #DocTISProject has been granted a six-month extension by @EU_Commission to complete its clinical trial in #IMIDs, ensuring robust patient follow-up and high-quality final results. 🔗 doctis.eu/doctis-six-mon… #immunemediated #IMID #AutoimmuneTherapies #IMIDResearch
👩🔬 Meet the people behind #DocTISProject! 🔬 In our first young researchers interview, Yolanda Guillén (@IMIDomics) shares how advanced molecular and computational technologies help better understand patient responses. 🔎 doctis.eu/yolanda-guille… #IMID #IMIDs #EUResearch
Today, we participated in the @DoctisEU 5th General Assembly meeting (@VHIR_) 🗣️@hoheyn, our Single Cell Genomics Group Leader, presented the results of WP4, which focuses on molecular data generation and our latest advancements #IMID #IMIDResearch #DocTISProject
🩺 #UlcerativeColitis is a chronic immune-mediated inflammatory disease (#IMID) that impacts patients’ quality of life. 🧬 At #DocTISProject, we advance #IMIDResearch to improve therapeutic strategies and patient outcomes. 🔎 Learn more: doctis.eu/ulcerative-col… #EUResearch
💊 The #DocTISProject hosted a webinar earlier this year on discovering combination therapies for Immune-Mediated Inflammatory Diseases #IMIDs. 📢 Dr. Sara Marsal from @vallhebron & @VHIR_ introduced the project, outlining its scope and objectives. #IMID
💊 Advancing combination therapies for #IMIDs requires robust molecular data and strong clinical–research integration. 📢 Dr @hoheyn (@cnag_eu) presented Work Package 4 at the #DocTISProject webinar, focusing on molecular data generation from IMID Biobank patients. #IMID
📣 Dr @hoheyn (@cnag_eu) presented research using data generated within #DocTISProject at the “Single cell-omics and the Human Cell Atlas” event, organised by @FundacionAreces and @SpringerNature. 👉 More: doctis.eu/single-cell-om… #SingleCellOmics #HumanCellAtlas #IMIDResearch
📢#DocTISProject will be at #IMMUNOLOGY2025! 🗣️@ToniJuliaC from @VHIR_ will present a collaborative study with CNAG and other partners: “Uncovering combination therapies for immune-mediated inflammatory diseases through systems biology analysis of longitudinal patient data"
🚀 #DocTISProject at #Immunology2025, the annual meeting of @ImmunologyAAI! 🚨 Don’t miss @ToniJuliaC's presentation on Monday, 5 May at 16:15 in Room 312 of @HIConventionCtr! 🚨 👉 Learn more: doctis.eu/doctis-researc… #Immunology #AAI2025 #IMID #IMIDs #AutoimmuneTherapies
🔬 The #DocTISProject single-cell atlas will be presented at @ACRheum´s #ACR25 in Chicago, the world’s leading #Rheumatology meeting. 🧬 @VHIR_’s Dr. @ToniJuliaC will showcase groundbreaking scRNA-seq insights. 👉 Learn more: doctis.eu/single-cell-at… #IMID #IMIDs #IMIDResearch
🩺 On #WorldHealthDay 2026, @WHO highlights how science drives global health 🔬 Progress depends on cooperation across researchers, clinicians & institutions. #DocTISProject applies this approach to advance treatments for #IMIDs 👉 doctis.eu #TogetherForScience
🎄 As Christmas approaches, the #DocTISProject reflects on a year of collaboration and progress in #IMIDResearch. 🔬 We continue working towards better, more personalised #AutoimmuneTherapies for people living with #IMIDs. 🔗 Learn more: doctis.eu #IMID
🧬 On #RareDiseaseDay, taking place tomorrow, #DocTISProject supports @eurordis and reaffirms its commitment to advancing research to address unmet medical needs and ensure no patient is left behind. 🔎 Learn more: doctis.eu/rare-disease-d… #IMID #IMIDs #AutoimmuneTherapies
🧬 The #DocTISProject held its final Scientific Advisory Board meeting as we move towards completion in June 2026. 🙏 We thank the Board for their continuous guidance and support, helping advance progress in #IMIDs and #AutoimmuneTherapies. 🌐 doctis.eu #IMID
The study led by @cnag_eu and published in @NatureMedicine, which uses data from the #DocTISProject and maps cellular inflammation at an unprecedented scale, has been featured on one of Spain’s main national TV channels. More info:👉 doctis.eu/cellular-infla… #SingleCell #IMIDs
🙌¡Nuestro atlas de la inflamación, de nuevo en TV! Un grupo de investigadores de CNAG publican el 1º atlas celular de la inflamación, que ha servido para desarrollar una herramienta IA para mejorar el diagnóstico de pacientes 📺Fuente: @A3Noticias 🔗cnag.eu/news/first-cel…
🔬 #DocTISProject data featured in @NatureMedicine! 🧬 DocTIS contributed to a @cnag_eu-led study on cellular inflammation, developed by @hoheyn, @jc_nietos, @ljimenezgracia, @DMasper0, @saguilarfer, @fcraighero and collaborators. 🔗 doctis.eu/cellular-infla… #NatureMedicine
💊 Patient selection and characterisation are key to research on combination therapies for #IMIDs. 📢 During a #DocTISProject webinar, Dr Maria López Lasanta from H@vallhebron hospital presented the clinical features of #IMID-Biobank patients within WP3 (Patient Selection).
🔬 Groundbreaking #DocTISProject study shared at #Viszeralmedizin 2025! 👩🔬 Prof. Britta Siegmund (@Charite) presented findings on how patients with different #IMIDs respond to targeted therapies using single-cell RNA sequencing. 🔗 doctis.eu/doctis-study-v… #IMIDResearch
🧬 What is #DocTISProject? 🩺 #IMIDs affect millions worldwide, but not all patients respond in the same way. 🔬 DocTIS combines clinical and molecular data with systems biology to advance more personalised treatments. 🔎 Learn more: doctis.eu #IMIDResearch
📢 As part of the #DocTISProject series, we feature Adrià Aterido, computational biologist at @VHIR_. 🧬 His work uses #MultiOmics and #SystemsBiology to uncover disease mechanisms and support therapies for #IMIDs. 👉 doctis.eu/adria-aterido-… #DataDrivenMedicine #IMID
📊 Turning data into better treatment decisions 🔬 Sergio Martínez (@IMIDomics) shares how data analysis helps understand patient responses and identify effective drug combinations in #IMIDs. 🔎 doctis.eu/sergio-martine… #DataScience #DocTISProject #IMIDResearch #EUResearch
🩺 On #WorldHealthDay 2026, @WHO highlights how science drives global health 🔬 Progress depends on cooperation across researchers, clinicians & institutions. #DocTISProject applies this approach to advance treatments for #IMIDs 👉 doctis.eu #TogetherForScience
👩🔬 Meet the people behind #DocTISProject! 🔬 In our first young researchers interview, Yolanda Guillén (@IMIDomics) shares how advanced molecular and computational technologies help better understand patient responses. 🔎 doctis.eu/yolanda-guille… #IMID #IMIDs #EUResearch
🧬 The #DocTISProject held its final Scientific Advisory Board meeting as we move towards completion in June 2026. 🙏 We thank the Board for their continuous guidance and support, helping advance progress in #IMIDs and #AutoimmuneTherapies. 🌐 doctis.eu #IMID
🧬 What is #DocTISProject? 🩺 #IMIDs affect millions worldwide, but not all patients respond in the same way. 🔬 DocTIS combines clinical and molecular data with systems biology to advance more personalised treatments. 🔎 Learn more: doctis.eu #IMIDResearch
🩺 #UlcerativeColitis is a chronic immune-mediated inflammatory disease (#IMID) that impacts patients’ quality of life. 🧬 At #DocTISProject, we advance #IMIDResearch to improve therapeutic strategies and patient outcomes. 🔎 Learn more: doctis.eu/ulcerative-col… #EUResearch
📣 Dr @hoheyn (@cnag_eu) presented research using data generated within #DocTISProject at the “Single cell-omics and the Human Cell Atlas” event, organised by @FundacionAreces and @SpringerNature. 👉 More: doctis.eu/single-cell-om… #SingleCellOmics #HumanCellAtlas #IMIDResearch
🧬 On #RareDiseaseDay, taking place tomorrow, #DocTISProject supports @eurordis and reaffirms its commitment to advancing research to address unmet medical needs and ensure no patient is left behind. 🔎 Learn more: doctis.eu/rare-disease-d… #IMID #IMIDs #AutoimmuneTherapies
💊 Advancing combination therapies for #IMIDs requires robust molecular data and strong clinical–research integration. 📢 Dr @hoheyn (@cnag_eu) presented Work Package 4 at the #DocTISProject webinar, focusing on molecular data generation from IMID Biobank patients. #IMID
The study led by @cnag_eu and published in @NatureMedicine, which uses data from the #DocTISProject and maps cellular inflammation at an unprecedented scale, has been featured on one of Spain’s main national TV channels. More info:👉 doctis.eu/cellular-infla… #SingleCell #IMIDs
🙌¡Nuestro atlas de la inflamación, de nuevo en TV! Un grupo de investigadores de CNAG publican el 1º atlas celular de la inflamación, que ha servido para desarrollar una herramienta IA para mejorar el diagnóstico de pacientes 📺Fuente: @A3Noticias 🔗cnag.eu/news/first-cel…
🔬 #DocTISProject data featured in @NatureMedicine! 🧬 DocTIS contributed to a @cnag_eu-led study on cellular inflammation, developed by @hoheyn, @jc_nietos, @ljimenezgracia, @DMasper0, @saguilarfer, @fcraighero and collaborators. 🔗 doctis.eu/cellular-infla… #NatureMedicine
💊 Patient selection and characterisation are key to research on combination therapies for #IMIDs. 📢 During a #DocTISProject webinar, Dr Maria López Lasanta from H@vallhebron hospital presented the clinical features of #IMID-Biobank patients within WP3 (Patient Selection).
🎄 As Christmas approaches, the #DocTISProject reflects on a year of collaboration and progress in #IMIDResearch. 🔬 We continue working towards better, more personalised #AutoimmuneTherapies for people living with #IMIDs. 🔗 Learn more: doctis.eu #IMID
🔬 #DocTISProject has been granted a six-month extension by @EU_Commission to complete its clinical trial in #IMIDs, ensuring robust patient follow-up and high-quality final results. 🔗 doctis.eu/doctis-six-mon… #immunemediated #IMID #AutoimmuneTherapies #IMIDResearch
🔬 New interview in our #DocTISProject series. 🎤 We spoke with #PereSantamaria from @idibaps: “By combining drugs intelligently, patients who do not respond to #monotherapies can be helped”. 👉 Discover more: doctis.eu/pere-santamari… #IDIBAPS #Autoimmunity #IMID #IMIDs
💊 The #DocTISProject hosted a webinar earlier this year on discovering combination therapies for Immune-Mediated Inflammatory Diseases #IMIDs. 📢 Dr. Sara Marsal from @vallhebron & @VHIR_ introduced the project, outlining its scope and objectives. #IMID
🔬 Our #DocTISProject interview series continues! 🎤 Today: @RickMyers_PhD, CSO of @hudsonalpha. 📣 “I have high hopes for the combination therapy being successful”. 👉 Learn how #Genomics is advancing personalized #IMID treatment: doctis.eu/richard-myers-… #IMIDs #IMIDResearch
🔬 Meet the minds behind the #DocTISProject! 🎤 We spoke with @ErnestChoy1, Prof. & Head of #Rheumatology at @cardiffuni: 📣 “I expect more patients will achieve remission with combination biologic treatment”. 👉 doctis.eu/ernest-choy-pa… #IMID #IMIDs #IMIDResearch #Autoimmune
📣 In our latest PI interview, we speak with Giampiero Girolomoni, Head of the #Dermatology Section at @UniVerona: 🗨️ “I was captivated by the ambitious goals of the #DocTISProject”. 👉 Read more: doctis.eu/giampiero-giro… #IMID #IMIDs #AutoimmuneTherapies #IMIDResearch
Avui acollim l'Assamblea General del projecte @DoctisEU en la qual es presenten els resultats obtinguts al llarg dels 5 anys de funcionament del #DocTISProject. La Dra. Begoña Benito, directora del #VHIR, ha destacat la importància de les fites aconseguides. #IMIDs
🔬 #DocTISProject has been granted a six-month extension by @EU_Commission to complete its clinical trial in #IMIDs, ensuring robust patient follow-up and high-quality final results. 🔗 doctis.eu/doctis-six-mon… #immunemediated #IMID #AutoimmuneTherapies #IMIDResearch
🔬 Our #DocTISProject interview series continues! 🎤 Today: @RickMyers_PhD, CSO of @hudsonalpha. 📣 “I have high hopes for the combination therapy being successful”. 👉 Learn how #Genomics is advancing personalized #IMID treatment: doctis.eu/richard-myers-… #IMIDs #IMIDResearch
🧬 On #RareDiseaseDay, taking place tomorrow, #DocTISProject supports @eurordis and reaffirms its commitment to advancing research to address unmet medical needs and ensure no patient is left behind. 🔎 Learn more: doctis.eu/rare-disease-d… #IMID #IMIDs #AutoimmuneTherapies
📢 A #DocTISProject study will be presented at #Viszeralmedizin2025! 🎤 Prof. Britta Siegmund (@ChariteBerlin) will share new findings at leading #Gastroenterology event. 📍 Sept 19 🌆 Leipzig, Germany 🔗 doctis.eu/doctis-congres… #IMID #IMIDs #IMIDResearch #MedicalResearch
🧬 What is #DocTISProject? 🩺 #IMIDs affect millions worldwide, but not all patients respond in the same way. 🔬 DocTIS combines clinical and molecular data with systems biology to advance more personalised treatments. 🔎 Learn more: doctis.eu #IMIDResearch
🩺 #UlcerativeColitis is a chronic immune-mediated inflammatory disease (#IMID) that impacts patients’ quality of life. 🧬 At #DocTISProject, we advance #IMIDResearch to improve therapeutic strategies and patient outcomes. 🔎 Learn more: doctis.eu/ulcerative-col… #EUResearch
🔬 The #DocTISProject single-cell atlas will be presented at @ACRheum´s #ACR25 in Chicago, the world’s leading #Rheumatology meeting. 🧬 @VHIR_’s Dr. @ToniJuliaC will showcase groundbreaking scRNA-seq insights. 👉 Learn more: doctis.eu/single-cell-at… #IMID #IMIDs #IMIDResearch
🔬 Groundbreaking #DocTISProject study shared at #Viszeralmedizin 2025! 👩🔬 Prof. Britta Siegmund (@Charite) presented findings on how patients with different #IMIDs respond to targeted therapies using single-cell RNA sequencing. 🔗 doctis.eu/doctis-study-v… #IMIDResearch
📢 Don’t miss Prof. Britta Siegmund from @ChariteBerlin at #Viszeralmedizin2025! 🎤 She will present latest findings from the #DocTISProject. 📅 Sept 19 🕒 15:05 CEST 📍 Leipzig, Germany (@CongressCenterL) 🔗 doctis.eu/doctis-congres… #Gastroenterology #MedicalResearch
🔬 New interview in our #DocTISProject series. 🎤 We spoke with #PereSantamaria from @idibaps: “By combining drugs intelligently, patients who do not respond to #monotherapies can be helped”. 👉 Discover more: doctis.eu/pere-santamari… #IDIBAPS #Autoimmunity #IMID #IMIDs
📢#DocTISProject findings will be showcased at #UEGWeek2025, Europe’s leading #Gastroenterology congress by @my_UEG. 🔬 On Oct 6, Prof. Britta Siegmund (@ChariteBerlin) presents the first large-scale scRNA-seq analysis of drug responses in #IMIDs. 👉 doctis.eu/doctis-ueg-week
📊 Turning data into better treatment decisions 🔬 Sergio Martínez (@IMIDomics) shares how data analysis helps understand patient responses and identify effective drug combinations in #IMIDs. 🔎 doctis.eu/sergio-martine… #DataScience #DocTISProject #IMIDResearch #EUResearch
🩺 On #WorldHealthDay 2026, @WHO highlights how science drives global health 🔬 Progress depends on cooperation across researchers, clinicians & institutions. #DocTISProject applies this approach to advance treatments for #IMIDs 👉 doctis.eu #TogetherForScience
👩🔬 Meet the people behind #DocTISProject! 🔬 In our first young researchers interview, Yolanda Guillén (@IMIDomics) shares how advanced molecular and computational technologies help better understand patient responses. 🔎 doctis.eu/yolanda-guille… #IMID #IMIDs #EUResearch
🎄 As Christmas approaches, the #DocTISProject reflects on a year of collaboration and progress in #IMIDResearch. 🔬 We continue working towards better, more personalised #AutoimmuneTherapies for people living with #IMIDs. 🔗 Learn more: doctis.eu #IMID
Today, we participated in the @DoctisEU 5th General Assembly meeting (@VHIR_) 🗣️@hoheyn, our Single Cell Genomics Group Leader, presented the results of WP4, which focuses on molecular data generation and our latest advancements #IMID #IMIDResearch #DocTISProject
📢 As part of the #DocTISProject series, we feature Adrià Aterido, computational biologist at @VHIR_. 🧬 His work uses #MultiOmics and #SystemsBiology to uncover disease mechanisms and support therapies for #IMIDs. 👉 doctis.eu/adria-aterido-… #DataDrivenMedicine #IMID
🔬 #DocTISProject data featured in @NatureMedicine! 🧬 DocTIS contributed to a @cnag_eu-led study on cellular inflammation, developed by @hoheyn, @jc_nietos, @ljimenezgracia, @DMasper0, @saguilarfer, @fcraighero and collaborators. 🔗 doctis.eu/cellular-infla… #NatureMedicine
📣 Dr @hoheyn (@cnag_eu) presented research using data generated within #DocTISProject at the “Single cell-omics and the Human Cell Atlas” event, organised by @FundacionAreces and @SpringerNature. 👉 More: doctis.eu/single-cell-om… #SingleCellOmics #HumanCellAtlas #IMIDResearch
Something went wrong.
Something went wrong.
United States Trends
- 1. Spirit N/A
- 2. New Day N/A
- 3. Kofi N/A
- 4. Jeff Cobb N/A
- 5. Prates N/A
- 6. Big E N/A
- 7. Elizabeth Warren N/A
- 8. #UFCPerth N/A
- 9. Inoue N/A
- 10. Kentucky Derby N/A
- 11. Pocahontas N/A
- 12. Tonga Loa N/A
- 13. JC Mateo N/A
- 14. #ARSFUL N/A
- 15. #LoveYouTeacherSeriesEP8 N/A
- 16. #Caturday N/A
- 17. Ticketmaster N/A
- 18. Delta N/A
- 19. Good Saturday N/A
- 20. West Ham N/A